Who invested in Adamas Pharmaceuticals?
Adamas Pharmaceuticals's investors include Mohr Davidow Ventures, DAG Ventures, Northgate Capital and Aeris Capital.
United States · Series D startup
4 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$82Mraised across 4 rounds since 2005, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by onbiovc.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Adamas Pharmaceuticals's investors include Mohr Davidow Ventures, DAG Ventures, Northgate Capital and Aeris Capital.
Adamas Pharmaceuticals has raised $82M across 4 rounds since 2005.
Adamas Pharmaceuticals's most recent round was a Series D of $40M in Oct 2009.
Its most recent round, $40M in Oct 2009, is also its largest on record.
Adamas Pharmaceuticals's first round on record, in May 2005, was backed by Mohr Davidow Ventures.
Adamas Pharmaceuticals's latest named round is a Series D, in Oct 2009.
Adamas Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.